Aktienanalyse zu Rocket One Inc (RKTO)

$0.691

+0.012 (+1.68%)Zum Schluss

Loading chart…

High: 0.706
Open: 0.680
VWAP: 0.69
Vol: 147.17K
Mkt Cap: —
Low: 0.680
Amount: 101.91K
EV/EBITDA, TTM: 0.00

Rocket One Inc., formerly Hoth Therapeutics, Inc., is focused on developing and commercializing infrastructure for the orbital economy, including nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The Company holds exclusive rights to certain technologies, including a nanomagnetic matrix multiplier architecture intended as a hardware accelerator for machine learning and AI workloads, and related magnetic memory technology with potential applications in radiation-tolerant computing for defense and space systems. The Company is also positioned to pursue opportunities in nano-launch systems and nanosatellite deployment. The Company's biotechnology pipeline includes HT-001, HT-KIT, HT-ALZ, and GDNF-based metabolic program.

hoththerapeutics.com

AI analysis of Rocket One Inc (RKTO)

sell

Rocket One Inc is not a good buy right now due to its extremely low RSI of 13.885, indicating oversold conditions, and a staggering year-to-date change of -47.80%.

Bewertungskennzahlen

The current forward P/E ratio for Rocket One Inc (RKTO) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Event-Zeitleiste

2026-08-11 (ET)